Considerations for Certain Concomitant Medications in Patients With COVID-19

Posted on | Posted on John Murphy | Leave a Comment on Considerations for Certain Concomitant Medications in Patients With COVID-19

Authors: NIH Patients with COVID-19 who are receiving concomitant medications (e.g., angiotensin-converting enzyme [ACE] inhibitors, angiotensin receptor blockers [ARBs], statins, systemic or inhaled corticosteroids, nonsteroidal anti-inflammatory drugs, acid-suppressive therapy) for underlying medical conditions should not discontinue these medications during acute management of COVID-19 unless discontinuation is otherwise warranted by their clinical condition (AIIa for ACE inhibitors and […]

Pathophysiology of COVID-19: Mechanisms Underlying Disease Severity and Progression

Posted on | Posted on John Murphy | Leave a Comment on Pathophysiology of COVID-19: Mechanisms Underlying Disease Severity and Progression

Authors: Mary Kathryn Bohn, Alexandra Hall, Lusia Sepiashvili, Benjamin Jung, Shannon Steele, and Khosrow Adeli Abstract The global epidemiology of coronavirus disease 2019 (COVID-19) suggests a wide spectrum of clinical severity, ranging from asymptomatic to fatal. Although the clinical and laboratory characteristics of COVID-19 patients have been well characterized, the pathophysiological mechanisms underlying disease severity and progression remain unclear. This […]

Complications Coronavirus Can Cause

Posted on | Posted on John Murphy | Leave a Comment on Complications Coronavirus Can Cause

Authors: WebMD If you have COVID-19, the illness that comes from infection with the recently discovered coronavirus, your symptoms may be relatively mild and manageable at home. That’s true for most people. But if you’re older or have another illness such as diabetes or heart disease, you’re more at risk for the serious form of COVID-19. Some people — about 1 […]

Interferons (Alfa, Beta)

Posted on | Posted on John Murphy | Leave a Comment on Interferons (Alfa, Beta)

Authors: NIH Interferons are a family of cytokines with antiviral properties. They have been suggested as a potential treatment for COVID-19 because of their in vitro and in vivo antiviral properties. Recommendation The COVID-19 Treatment Guidelines Panel recommends against the use of interferons for the treatment of patients with severe or critical COVID-19, except in a clinical trial (AIII). There is insufficient evidence to […]

Cytokine Storm

Posted on | Posted on John Murphy | Leave a Comment on Cytokine Storm

Authors: David C. Fajgenbaum, M.D., and Carl H. June, M.D. The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has reminded us of the critical role of an effective host immune response and the devastating effect of immune dysregulation. This year marks 10 years since the first description of a cytokine storm that developed after chimeric […]

Ivermectin

Posted on | Posted on John Murphy | Leave a Comment on Ivermectin

Authors: NIH Ivermectin is a Food and Drug Administration (FDA)-approved antiparasitic drug that is used to treat several neglected tropical diseases, including onchocerciasis, helminthiases, and scabies.1 It is also being evaluated for its potential to reduce the rate of malaria transmission by killing mosquitoes that feed on treated humans and livestock.2 For these indications, ivermectin has been […]

OBGYN explains why a COVID vaccine might affect menstrual cycles

Posted on | Posted on John Murphy | Leave a Comment on OBGYN explains why a COVID vaccine might affect menstrual cycles

Authors: Kate Larsen SAN FRANCISCO — Anecdotal evidence from women around the country has led to questions about how COVID-19 vaccines may affect women’s menstrual cycles. When ABC7 News reporter, Kate Larsen, posted the question on social media, it became clear that a lot of women are experiencing cycle changes, and are wondering if it’s […]

Coronavirus disease 2019 (COVID-19)

Posted on | Posted on John Murphy | Leave a Comment on Coronavirus disease 2019 (COVID-19)

Authors: Nicholas J. Beeching, MA, BM BCh, FRCP, FRACP, FFTM RCPS (Glasg), FESCMID, DCH, DTM&H, Tom E. Fletcher, MBE, PhD, MBChB, MRCP, DTM&H, Robert Fowler, MDCM, MS (Epi), FRCP(C) © BMJ Publishing Group 2021 Coronavirus disease 2019 (COVID-19) is an infectious acute respiratory disease caused by a novel coronavirus. The World Health Organization (WHO) was informed […]

COVID-19 (coronavirus): Long-term effects

Posted on | Posted on John Murphy | Leave a Comment on COVID-19 (coronavirus): Long-term effects

Authors: Mayo Clinic Staff COVID-19 symptoms can sometimes persist for months. The virus can damage the lungs, heart and brain, which increases the risk of long-term health problems. Most people who have coronavirus disease 2019 (COVID-19) recover completely within a few weeks. But some people — even those who had mild versions of the disease […]

Impact of COVID-19 and lockdown on mental health of children and adolescents: A narrative review with recommendations☆

Posted on | Posted on John Murphy | Leave a Comment on Impact of COVID-19 and lockdown on mental health of children and adolescents: A narrative review with recommendations☆

Authors: Shweta Singh,a Deblina Roy,b,⁎ Krittika Sinha,c Sheeba Parveen,c Ginni Sharma,c and Gunjan Josh COVID-19 pandemic and lockdown has brought about a sense of fear and anxiety around the globe. This phenomenon has led to short term as well as long term psychosocial and mental health implications for children and adolescents. The quality and magnitude of impact on minors is determined […]